GO
Loading...

Eli Lilly and Co

More

  • Midday Glance: Pharmaceuticals companies Friday, 1 Aug 2014 | 1:35 PM ET

    Baxter International Inc. rose$. 38 or. 5 percent, to $75.07. Bristol-Myers Squibb Co. fell$. 73 or 1.4 percent, to $49.89. Hospira fell$. 88 or 1.6 percent, to $54.59.

  • FDA approves Lilly, Boehringer diabetes drug Friday, 1 Aug 2014 | 1:29 PM ET

    Federal regulators have approved a new treatment from U.S. drugmaker Eli Lilly and Co. and its German counterpart, Boehringer Ingelheim, for the most common form of diabetes.

  • Early Glance: Pharmaceuticals companies Friday, 1 Aug 2014 | 11:08 AM ET

    Baxter International Inc. rose$. 70 or. 9 percent, to $75.39. Bristol-Myers Squibb Co. rose$. 15 or. 3 percent, to $50.77. Hospira rose$. 49 or. 9 percent, to $55.96.

  • Final Glance: Pharmaceuticals companies Thursday, 31 Jul 2014 | 6:04 PM ET

    Baxter International Inc. fell $1.40 or 1.8 percent, to $74.69. Bristol-Myers Squibb Co. fell$. 50 or 1.0 percent, to $50.62. Hospira fell$. 74 or 1.3 percent, to $55.47.

  • Final Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 25 or. 3 percent, to $76.09. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $51.12. Hospira rose $4.31 or 8.3 percent, to $56.21.

  • Midday Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 1:22 PM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $76.41. Bristol-Myers Squibb Co. fell$. 03 or. 1 percent, to $50.98. Hospira rose $4.08 or 7.9 percent, to $55.98.

  • Early Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 10:42 AM ET

    Baxter International Inc. rose$. 54 or. 7 percent, to $76.88. Bristol-Myers Squibb Co. fell$. 29 or. 6 percent, to $50.73. Hospira rose $2.11 or 4.1 percent, to $54.01.

  • Final Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 6:04 PM ET

    Baxter International Inc. fell$. 18 or. 2 percent, to $76.47. Bristol-Myers Squibb Co. rose$. 41 or. 8 percent, to $49.80. Hospira rose$. 12 or. 2 percent, to $51.84.

  • Midday Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 1:31 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $76.38. Bristol-Myers Squibb Co. rose$. 02 or percent, to $49.41. Hospira rose $1.03 or 2.0 percent, to $52.75.

  • Early Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 10:33 AM ET

    Baxter International Inc. fell$. 10 or. 1 percent, to $76.55. Bristol-Myers Squibb Co. fell$. 21 or. 4 percent, to $49.18. Hospira rose $2.43 or 4.7 percent, to $54.15.

  • *Novo expects to launch in first EU markets in H1 2015. *Shares in Novo rise 1.6 percent. Prospects for degludec- already on sale separately in Europe under the brand name Tresiba- and the new combination with Victoza are critical for Novo, which is the world's biggest insulin maker.

  • Final Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $49.46. Hospira rose $1.16 or 2.3 percent, to $51.82.

  • US STOCKS-Wall St flat as Caterpillar offsets Facebook Thursday, 24 Jul 2014 | 2:49 PM ET

    *Caterpillar weighs on Dow, Facebook hits record on results. NEW YORK, July 24- U.S. stocks barely budged on Thursday as corporate earnings painted a mixed picture of the economy, though the S&P 500 eked out a record intraday high for the third straight session.

  • Midday Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $49.52. Hospira rose$. 74 or 1.5 percent, to $51.40.

  • *U.S. stocks edge up along with MSCI world index. "The lower-than-expected U.S. initial jobless claims has made people focus on the improving labor market situation," said Ian Lyngen, senior government bond strategist, at CRT Capital in Stamford, Connecticut.

  • Early Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $49.16. Hospira rose$. 03 or. 1 percent, to $50.69.

  • NEW YORK, July 24- Major global stock markets edged higher while the euro rose from an eight-month low against the U.S. dollar on Thursday following upbeat euro zone data and stronger-than-expected U.S. earnings.

  • US STOCKS-Results, jobs data buoy Wall St, S&P eyes 2,000 Thursday, 24 Jul 2014 | 10:54 AM ET

    NEW YORK, July 24- The S&P 500 hit a record high for a third straight session on Thursday, lifted by jobs data and earnings, but a weak reading in new home sales kept other key stock indexes little changed.

  • July 24- Eli Lilly and Co's quarterly revenue plunged due to generic competition for its Cymbalta depression drug and its Evista osteoporosis treatment, but cost controls helped earnings beat forecasts.

  • *Facebook rallies on results; market value near IBM's. *U.S. manufacturing data due; Europe, China upbeat. NEW YORK, July 24- U.S. stock index futures rose on Thursday, following a record close on the S&P 500 index, lifted by strong job market data in the United States and overseas factory readings, while better than forecast results sent Facebook shares rallying.